Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Jan;58(675):20–24. doi: 10.1136/pgmj.58.675.20

The penetration of metronidazole into synovial fluid.

M A Sattar, M G Sankey, M I Cawley, C M Kaye, J E Holt
PMCID: PMC2426234  PMID: 7088754

Abstract

Six patients with non-infected synovial effusions, associated either with inflammatory or degenerative arthropathy and requiring diagnostic or therapeutic aspiration, were given a short course of 400 mg metronidazole (Flagyl) 8-hourly for 3 doses. Serum and synovial fluid (SF) were sampled frequently during this time, and assayed for metronidazole by a specific high pressure liquid-chromatographic method. It was found that concentrations of metronidazole in SF reached those in serum after a short time-lag, and thereafter approximated to the serum concentration. With this regimen, metronidazole concentrations were readily achieved in synovial fluid, above the minimum inhibitory concentrations for most susceptible anaerobes. These results indicate that the drug freely enters the synovial fluid and suggests that metronidazole would prove effective in the treatment of septic arthritis due to anaerobic bacteria.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amon I., Amon K., Franke G., Mohr C. Pharmacokinetics of Metronidazole in pregnant women. Chemotherapy. 1981;27(2):73–79. doi: 10.1159/000237958. [DOI] [PubMed] [Google Scholar]
  2. Barling R. W., Selkon J. B. The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrob Chemother. 1978 May;4(3):203–227. doi: 10.1093/jac/4.3.203. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G., Finegold S. M. Anaerobic pleuropulmonary infections. Medicine (Baltimore) 1972 Nov;51(6):413–450. doi: 10.1097/00005792-197211000-00001. [DOI] [PubMed] [Google Scholar]
  4. Bartlett J. G., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972 Nov 16;287(20):1006–1010. doi: 10.1056/NEJM197211162872002. [DOI] [PubMed] [Google Scholar]
  5. Bergan T., Arnold E. Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories. Chemotherapy. 1980;26(4):231–241. doi: 10.1159/000237911. [DOI] [PubMed] [Google Scholar]
  6. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs. 1978 Nov;16(5):387–417. doi: 10.2165/00003495-197816050-00002. [DOI] [PubMed] [Google Scholar]
  7. Chow A. W., Guze L. B. Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) 1974 Mar;53(2):93–126. [PubMed] [Google Scholar]
  8. Cohen L. E., McNeill C. J., Wells R. F. Clindamycin-associated colitis. JAMA. 1973 Mar 19;223(12):1379–1380. [PubMed] [Google Scholar]
  9. DOUGLAS G. W., LEVIN R. H., SOKOLOFF L. INFECTIOUS ARTHRITIS COMPLICATING NEOPLASTIC DISEASE. N Engl J Med. 1964 Feb 6;270:299–302. doi: 10.1056/NEJM196402062700609. [DOI] [PubMed] [Google Scholar]
  10. Eykyn S. J., Phillips I. Metronidazole and anaerobic sepsis. Br Med J. 1976 Dec 11;2(6049):1418–1421. doi: 10.1136/bmj.2.6049.1418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Felner J. M., Dowell V. R., Jr Anaerobic bacterial endocarditis. N Engl J Med. 1970 Nov 26;283(22):1188–1192. doi: 10.1056/NEJM197011262832203. [DOI] [PubMed] [Google Scholar]
  12. Finegold S. M., Bartlett J. G., Chow A. W., Flora D. J., Gorbach S. L., Harder E. J., Tally F. P. Management of anaerobic infections. Ann Intern Med. 1975 Sep;83(3):375–389. doi: 10.7326/0003-4819-83-3-375. [DOI] [PubMed] [Google Scholar]
  13. Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
  14. HEINEMAN H. S., BRAUDE A. I. ANAEROBIC INFECTION OF THE BRAIN. OBSERVATIONS ON EIGHTEEN CONSECUTIVE CASES OF BRAIN ABSCESS. Am J Med. 1963 Nov;35:682–697. doi: 10.1016/0002-9343(63)90139-6. [DOI] [PubMed] [Google Scholar]
  15. Houghton G. W., Smith J., Thorne P. S., Templeton R. The pharmacokinetics of oral and intravenous metronidazole in man. J Antimicrob Chemother. 1979 Sep;5(5):621–623. doi: 10.1093/jac/5.5.621. [DOI] [PubMed] [Google Scholar]
  16. Houghton G. W., Thorne P. S., Smith J., Templeton R., Collier J. Comparison of the pharmacokinetics of metronidazole in healthy female volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol. 1979 Oct;8(4):337–341. doi: 10.1111/j.1365-2125.1979.tb04715.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KELLGREN J. H., BALL J., FAIRBROTHER R. W., BARNES K. L. Suppurative arthritis complicating rheumatoid arthritis. Br Med J. 1958 May 24;1(5081):1193–1200. doi: 10.1136/bmj.1.5081.1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kaye C. M., Sankey M. G., Thomas L. A. A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood. Br J Clin Pharmacol. 1980 May;9(5):528–529. doi: 10.1111/j.1365-2125.1980.tb05856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nettles J. L., Kelly P. J., Martin W. J., Washington J. A. Musculoskeletal infections due to bacteroides. J Bone Joint Surg Am. 1969 Mar;51(2):230–238. [PubMed] [Google Scholar]
  20. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  21. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  22. Swartz M. N. Anaerobic bacteria in central nervous system infections. J Fla Med Assoc. 1970 Jan;57(1):19–23. [PubMed] [Google Scholar]
  23. Tally F. P., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with metronidazole. Antimicrob Agents Chemother. 1975 May;7(5):672–675. doi: 10.1128/aac.7.5.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wells R. F., Cohen L. E., McNeill C. J. Letter: Clindamycin and pseudomembranous colitis. Lancet. 1974 Jan 12;1(7846):66–66. doi: 10.1016/s0140-6736(74)93067-0. [DOI] [PubMed] [Google Scholar]
  25. Wilkins T. D., Thiel T. Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother. 1973 Jan;3(1):136–137. doi: 10.1128/aac.3.1.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ziment I., Davis A., Finegold S. M. Joint infection by anaerobic bacteria: a case report and review of the literature. Arthritis Rheum. 1969 Dec;12(6):627–635. doi: 10.1002/art.1780120610. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES